Top
Poly (ADP-Ribose) Polymerase Inhibitor, ABT888, Improved Cisplatin Effect in Human Oral Cell Carcinoma
Poly (ADP-Ribose) Polymerase Inhibitor, ABT888, Improved Cisplatin Effect in Human Oral Cell Carcinoma
DOI: 10.3390/biomedicines9070771, Volume: 9, Issue: 7, Pages: 0-0
Article Type: research-article,
Article History
received:
accepted:
published:
-
-
-
- Altmetric
https://www.researchpad.co/tools/openurl?pubtype=&doi=10.3390/biomedicines9070771&title=Poly (ADP-Ribose) Polymerase Inhibitor, ABT888, Improved Cisplatin Effect in Human Oral Cell Carcinoma&author=&keyword=[{keywordId=4, uniqueName=apoptosis, name=Apoptosis, contentId=301464}, {keywordId=40, uniqueName=oral-cancer, name=Oral cancer, contentId=301464}, {keywordId=303, uniqueName=cisplatin, name=cisplatin, contentId=301464}, {keywordId=363621, uniqueName=human-oral-cell-carcinoma, name=human oral cell carcinoma, contentId=301464}, {keywordId=363622, uniqueName=parp-inhibitors-(parpi), name=PARP inhibitors (PARPi), contentId=301464}, {keywordId=363623, uniqueName=veliparib-(abt888), last=true, name=veliparib (ABT888), contentId=301464}],[{keywordId=4, uniqueName=apoptosis, name=Apoptosis, contentId=301464}, {keywordId=40, uniqueName=oral-cancer, name=Oral cancer, contentId=301464}, {keywordId=303, uniqueName=cisplatin, name=cisplatin, contentId=301464}, {keywordId=363621, uniqueName=human-oral-cell-carcinoma, name=human oral cell carcinoma, contentId=301464}, {keywordId=363622, uniqueName=parp-inhibitors-(parpi), name=PARP inhibitors (PARPi), contentId=301464}, {keywordId=363623, uniqueName=veliparib-(abt888), last=true, name=veliparib (ABT888), contentId=301464}],[{keywordId=4, uniqueName=apoptosis, name=Apoptosis, contentId=301464}, {keywordId=40, uniqueName=oral-cancer, name=Oral cancer, contentId=301464}, {keywordId=303, uniqueName=cisplatin, name=cisplatin, contentId=301464}, {keywordId=363621, uniqueName=human-oral-cell-carcinoma, name=human oral cell carcinoma, contentId=301464}, {keywordId=363622, uniqueName=parp-inhibitors-(parpi), name=PARP inhibitors (PARPi), contentId=301464}, {keywordId=363623, uniqueName=veliparib-(abt888), last=true, name=veliparib (ABT888), contentId=301464}],[{keywordId=4, uniqueName=apoptosis, name=Apoptosis, contentId=301464}, {keywordId=40, uniqueName=oral-cancer, name=Oral cancer, contentId=301464}, {keywordId=303, uniqueName=cisplatin, name=cisplatin, contentId=301464}, {keywordId=363621, uniqueName=human-oral-cell-carcinoma, name=human oral cell carcinoma, contentId=301464}, {keywordId=363622, uniqueName=parp-inhibitors-(parpi), name=PARP inhibitors (PARPi), contentId=301464}, {keywordId=363623, uniqueName=veliparib-(abt888), last=true, name=veliparib (ABT888), contentId=301464}],[{keywordId=4, uniqueName=apoptosis, name=Apoptosis, contentId=301464}, {keywordId=40, uniqueName=oral-cancer, name=Oral cancer, contentId=301464}, {keywordId=303, uniqueName=cisplatin, name=cisplatin, contentId=301464}, {keywordId=363621, uniqueName=human-oral-cell-carcinoma, name=human oral cell carcinoma, contentId=301464}, {keywordId=363622, uniqueName=parp-inhibitors-(parpi), name=PARP inhibitors (PARPi), contentId=301464}, {keywordId=363623, uniqueName=veliparib-(abt888), last=true, name=veliparib (ABT888), contentId=301464}],[{keywordId=4, uniqueName=apoptosis, name=Apoptosis, contentId=301464}, {keywordId=40, uniqueName=oral-cancer, name=Oral cancer, contentId=301464}, {keywordId=303, uniqueName=cisplatin, name=cisplatin, contentId=301464}, {keywordId=363621, uniqueName=human-oral-cell-carcinoma, name=human oral cell carcinoma, contentId=301464}, {keywordId=363622, uniqueName=parp-inhibitors-(parpi), name=PARP inhibitors (PARPi), contentId=301464}, {keywordId=363623, uniqueName=veliparib-(abt888), last=true, name=veliparib (ABT888), contentId=301464}],&subject=
© 2024 Newgen KnowledgeWorks |
Privacy & Cookie Policy | Powered by: Nova